LoginRegister
    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedbackUnion Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...
    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop productionRising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...
    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MDHydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD
    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama CapitalWellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital
    Top priority on Delivery of Medicines through Speed Post: MinisterTop priority on Delivery of Medicines through Speed Post: Minister
    Lasa Supergenerics gets FDA nod for ProgesteroneLasa Supergenerics gets FDA nod for Progesterone
    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical AllianceShipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance
    SMS Pharma updates against USFDA statement on RanitidineSMS Pharma updates against USFDA statement on Ranitidine
    Lupin Contributes Rs 21 crores in battle against COVID-19Lupin Contributes Rs 21 crores in battle against COVID-19
    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1
    Lupin gets USFDA EIR for Nagpur FacilityLupin gets USFDA EIR for Nagpur Facility
    KKRs Envision Healthcare hires bank to explore debt restructuring: ReportKKR's Envision Healthcare hires bank to explore debt restructuring: Report
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X